IDXG Logo.jpg
Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
August 09, 2018 16:46 ET | Interpace Diagnostics Group, Inc.
Revenue Grew 43% Over the Prior Year’s Quarter and 14% Over the Prior Period Record Quarterly Revenue of $5.5 Million Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt Now Covered...
IDXG Logo.jpg
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018
August 01, 2018 08:30 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc., (“Interpace” or “the Company”) announced today that it will report its second quarter 2018 financial results...
Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
July 31, 2018 08:30 ET | Interpace Diagnostics Group, Inc.
PARSIPPANY, NJ, July 31, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...